Home » Archive by Category


San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

UC San Diego Part of New Effort to Fight Autoimmune Disorders

September 25, 2014 – 1:53 pm | Edit Post

The Division of Rheumatology, Allergy and Immunology at University of California, San Diego School of Medicine has been named a key site in a national, multi-institution, multi-year $41.6 million program to speed drug discovery, development, diagnostics and therapies for patients with autoimmune disorders, primarily rheumatoid arthritis (RA) and lupus erythematosus, which affect millions of Americans.

UC San Diego Health System Continues to Provide Exceptional Care by “Top Docs”

September 25, 2014 – 11:29 am | Edit Post

More than 100 physicians from UC San Diego Health System were named “Top Docs” in the annual San Diego Magazine “Physicians of Exceptional Excellence” annual survey. These physicians represent 40 diverse specialties, from internal medicine and oncology to obstetrics, cardiovascular and surgical care.

Modified vitamin D shows promise as treatment for pancreatic cancer

September 24, 2014 – 5:00 pm | Edit Post

LA JOLLA–A synthetic derivative of vitamin D was found by Salk Institute researchers to collapse the barrier of cells shielding pancreatic tumors, making this seemingly impenetrable cancer much more susceptible to therapeutic drugs.

Backed By a Baidu Founder, Allele Raises $7M to Reprogram Stem Cells

September 24, 2014 – 9:09 am | Edit Post

After subsisting mostly on Small Business Innovation Research grants and sales of laboratory reagents over the past 15 years, San Diego-based Allele Biotechnology & Pharmaceuticals says it has…
[[Click headline to continue reading.]]

Scripps to make artificial immune system

September 24, 2014 – 7:45 am | Edit Post

Scripps Research scientists to make an artificial immune system under a $7.9 million grant.

Avelas Biosciences completes $7.4M funding

September 23, 2014 – 4:50 pm | Edit Post

Cancer diagnostics developer Avelas Biosciences has raised $7.4 million.

Two new San Diego biotechs get $20 million

September 23, 2014 – 11:42 am | Edit Post

Avalon Ventures and GSK have placed $20 million in 2 new San Diego biotech companies.

“100K” Marathon: A Decades-Long Health Study Makes Its Business Case

September 23, 2014 – 3:30 am | Edit Post

For the past several months, 108 people, most of them in the Seattle area, have been under constant biomedical surveillance. And they like it. They’ve agreed to submit to a battery of medical…
[[Click headline to continue reading.]]

Looking Ahead: Whole Eye Transplant Under Development

September 22, 2014 – 11:55 am | Edit Post

The concept of a whole eye transplant seems futuristic, if not impossible. But with a $1million grant from the U.S. Department of Defense, researchers at University of California, San Diego School of Medicine hope to someday make implantation of an entire, functional eye a reality.

San Diego Meets the Xconomists: A Real-World Innovation Commons

September 22, 2014 – 11:52 am | Edit Post

The heat wave broke with impeccable timing, and we were grateful that “California weather” was back as San Diego’s innovation leaders gathered for Xconomy’s sixth annual networking event. Xconomy…
[[Click headline to continue reading.]]